Excerpts

In the multivariate data meta-analysis (fixed effects), there was a borderline significant association between sarcopenia and OS (fixed effects, HR = 1.20, 95% CI: 1.01, 1.44, P = 0.04, I 2 = 43%; k = 5; n = 831).

Statistical analyses of the differences between the AUC demonstrated that the incremental improvement in correct classifications achieved with the IV plus clinical variables model (as compared with clinical variables alone) was of borderline significance ( p = 0.04). 4.

Finally, the number of symptoms at diagnosis was a marginally significant predictor of the number of symptoms three months after recovery ( p = 0.04).

Results: The benefit of colchicine in reducing MACE risk was marginally significant (RR = 0.79, 95% CI: 0.63–0.99, p = 0.04, I 2 = 59%).

In response to treatment with pirfenidone, GAP I patients ( n = 26) did not show a meaningful change in the FVC slopes, whereas GAP II patients ( n = 51) showed a weakly significant reduction in FVC decline ( p = 0.04), and GAP III patients ( n = 26) showed a highly significant reduction in FVC decline ( p < 0.001).

A notable trend was seen toward increasing early interventions with CDT in patients being admitted for acute PE throughout our study period ( p = 0.04) ( Figure 2 ). 4.

The between-group difference at 2025 approached significance with a small-to-moderate effect ( p = 0.04; q = 0.06; δ ≈ 0.28–0.30).

Although the difference in Psychological Discomfort ( p = 0.094) did not reach statistical significance, the Functional Limitation domain stands out ( p = 0.041).

This difference was statistically significant, and an increasing trend was observed ( p = 0.041). 4.

Interestingly, LCDG induced a significant trend of reduction in Ruminococcus ( p = 0.042) and in IL-15 (mean change −173.4; p = 0.042).

Regarding lactate, a marginally significant negative association could be seen ( p = 0.042, 95% CI: −1.618–−0.293).

However, according to our marginally significant findings ( p = 0.044), we postulate that the end-diastolic cIMR may be rougher than the end-systolic values in KD patients.

A highly significant difference was found for the feeling of being flawed domain ( p = 0.044), with a mean score of 13.4 points.

The post hoc analysis revealed a significant difference between MS and MOGAD cohorts (mean difference −81.73 cm 3 , p = 0.012), and a borderline significant difference was noted between MS and HC groups (mean difference −71.4 cm 3 , p = 0.045) ( Figure 3 B).

The differences in the results for vertical atrophy of the alveolar process showed a tendency toward statistical significance ( p = 0.045) ( Figure 10 ).

Notably, our bCP group only showed a significant correlation between hip angle and maximal passive knee extension at T2, with a tendency towards significance at T1 ( p = 0.045).

PED reduction reached borderline significance ( p = 0.0455).

However, a significant difference emerged with respect to the NDI scores, which exhibited an increasing trend in values corresponding to deeper levels of subsidence ( p = 0.0459) with a mean of 10.7 pts for the 2–3 mm subgroup, 11.9 pts for 3–4 mm and 13.5 pts for ≥4 mm of implant migration into adjacent endplate ( Table 3 ). 4.

A similar trend was observed in the GJH-positive group, although the association reached only marginal significance (χ 2 = 3.967; p = 0.046; Cramer’s V = 0.1), which also represents a small effect size.

The association between years of clinical experience and EMST use reached borderline significance (χ 2 (4) = 9.71, p = 0.046).

Comparable to those results, Ramundo et al., reported, the upper pole location had a slightly significant association with malignancy using ACR-TIRADS (OR 6.92; 95% CI 1.02–46.90; p = 0.047) [ 38 ].

A borderline significant difference in age was observed between the PEEK and 3DPT cohorts (PEEK 59.67 vs. 3DPT 64.26; p = 0.047), and the 3DPT patients had a higher incidence of hypertension (3DPT 66.7%, 28/42 vs.

A borderline significant and weak positive correlation between ELP-3 and the smoking status of the CD patients was demonstrated (r = 0.196, p = 0.047) ( Supplementary Figure S1 and Table S1 ).

The immunoreactivity for MCP-1/ CCL2 in the polyps positively correlated with that for MCP-2/ CCL8 ( ρ = 0.46, p = 0.0001), while MCP-1/ CCL2′ s correlation with MCP-3/ CCL7 was weak and borderline significant ( ρ = 0.25, p = 0.047), and that between MCP-3/ CCL7 and MCP-2/ CCL8 was non-significant ( ρ = 0.25, p = 0.053). 3.2.

Assessment by SF-36 at D8 showed that the improvement in Quality of Life was marginally significant for the physical component (37.5 ± 7.9 vs. 42.0 ± 9.7; p = 0.047; ES = 0.88 (0.01; 1.75)) and unchanged for the mental component (36.8 ± 10.6 vs. 36.8 ± 10.2; p = 0.77; ES = 0.1 (−0.74; 0.94)).